Skip to main content
VYNE logo

VYNE

VYNE Therapeutics Inc.
$0.68 0.00 (-0.15%) At close · Jul 2
Market Cap
$22.68M
Shares
33,352,858

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 44
Total Value: $7,869,006
Total Shares: 13,158,914

Institutional Ownership Trend

13 quarters

Holder Concentration

Across 44 13F filers · Δ vs Dec 31, 2025
Top Holder
15.2%
Jun 2023 → Mar 2026 · range 15.2% – 31.9%
−4.7 pts
Top 5
57.3%
Jun 2023 → Mar 2026 · range 55.0% – 85.6%
−9.7 pts
Top 10
82.4%
Jun 2023 → Mar 2026 · range 81.3% – 98.9%
−3.6 pts
HHI
859
Jun 2023 → Mar 2026 · range 840 – 1,898
Broadly held−221

Quarterly Activity

vs Dec 31, 2025
New
8
Increased
10
Decreased
6
Sold Out
6
Unchanged
20
Holder count: +2
Institutional value: +65.9%
Shares held: +60.9%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 44 of 44
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1566044 CUSIP 92941V308 13F (30d) 1 filings 1 filers Visit website Investor relations